NA
SILK

Neuburgh Advisers’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Neuburgh Advisers’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$72K Buy
2,208
+1,856
+527% +$73.9K ﹤0.01% 823
2019
Q2 		$17K Buy
+352
New +$15K ﹤0.01% 892

Other funds holding SILK

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NVPX
Norwest Venture Partners XIII Palo Alto, California $25.8M AUM 76.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuburgh Advisers's SILK Position: Q3 2019 in Review

Neuburgh Advisers increased its Silk Road Medical, Inc. Common Stock (SILK) stake by 527% in Q3 2019, buying an estimated $73.9K and bringing the position to 2,208 shares worth $72K. The position accounts for ﹤0.01% of the portfolio, ranked #823.

Neuburgh Advisers first reported a position in SILK in Q2 2019 and has held it in 2 quarters since. 101 funds tracked by Wall St. Rank hold SILK as of Q3 2019.

  • Neuburgh Advisers held 2,208 shares of Silk Road Medical, Inc. Common Stock worth $72K as of Q3 2019.
  • Neuburgh Advisers bought 1,856 Silk Road Medical, Inc. Common Stock shares in Q3 2019, an estimated $73.9K.
  • Silk Road Medical, Inc. Common Stock made up ﹤0.01% of Neuburgh Advisers's portfolio in Q3 2019, its #823 holding.
  • Neuburgh Advisers first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and has held it in 2 quarters since.
  • 101 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.